Table 1.
Flavanones | Model | Disease/Condition | References |
---|---|---|---|
naringin | In vivo | MPP+-treated rats | Leem et al., 2014 [51] |
In vivo | 6-OHDA-injected mice | Kim et al., 2016 [52] | |
In vivo | 3-NP-injected rats | Gopinath and Sudhandiran, 2012 [53] | |
In vivo | aluminum-treated rats | Prakash et al., 2013 [54] | |
In vivo | colchicine-treated rats | Kumar et al., 2010 [55] | |
hesperidin | In vivo | 6-OHDA-injected mice | Antunes et al., 2014 [56] |
In vivo | 3-NP-treated mice | Menze et al., 2012 [57] | |
In vivo | APP/PS1–21 transgenic mice | Li et al., 2015 [58] | |
In vivo | APPswe/PS1dE9 transgenic mice | Wang et al., 2014 [59] | |
In vivo | ICV-STZ-injected mice | Javed et al., 2015 [60] | |
In vivo | AlCl3-injected rats | Thenmozhi et al., 2015 [61] | |
In vivo | AlCl3-injected rats | Thenmozhi et al., 2016 [62] | |
In vivo | 4-AP-treated rats KA-injected rat |
Chang et al., 2015 [63] | |
hesperetin | In vivo | Mice | Choi and Ahn, 2008 [64] |
In vivo | 6-OHDA-injected rats | Kiasalari et al., 2016 [65] | |
In vitro | staurosporine-treated cortical neurons cultures | Rainey-Smith et al., 2008 [66] | |
In vitro | H2O2-treated cortical neurons | Vauzour et al., 2007 [67] | |
neohesperidin | In vitro | H2O2-treated PC12 cells | Hwang et al., 2008 [68] |
naringenin | In vivo | ICV-STZ-injected rats | Khan et al., 2012 [69] |
In vivo | ICV-STZ-injected rats | Baluchnejadmojarad and Roghani, 2006 [70] | |
In vitro | Aβ-treated PC12 cells | Heo et al., 2004 [71] | |
In vitro | microglial cells | Wu et al., 2016 [72] | |
In vitro | LPS/IFN-γ exposed primary neuronal-glial cells | Vafeiadou et al., 2009 [73] | |
didymin | In vitro | H2O2-treated neuronal cells | Morelli et al, 2014 [74] |